Hiroshi Kasugai

2.6k total citations
56 papers, 1.9k citations indexed

About

Hiroshi Kasugai is a scholar working on Hepatology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hiroshi Kasugai has authored 56 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Hepatology, 18 papers in Epidemiology and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hiroshi Kasugai's work include Hepatocellular Carcinoma Treatment and Prognosis (37 papers), Liver Disease Diagnosis and Treatment (16 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers). Hiroshi Kasugai is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (37 papers), Liver Disease Diagnosis and Treatment (16 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers). Hiroshi Kasugai collaborates with scholars based in Japan, United States and Switzerland. Hiroshi Kasugai's co-authors include Yo Sasaki, Masatoshi Kudo, Yukio Osaki, Toshihito Seki, Hiroko Oka, Masaharu Tatsuta, Shigeru Okuda, J Kojima, Takashi Matsunaga and Shingo Ishiguro and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Hepatology.

In The Last Decade

Hiroshi Kasugai

52 papers receiving 1.8k citations

Peers

Hiroshi Kasugai
Hiroshi Kasugai
Citations per year, relative to Hiroshi Kasugai Hiroshi Kasugai (= 1×) peers Christian Mueller

Countries citing papers authored by Hiroshi Kasugai

Since Specialization
Citations

This map shows the geographic impact of Hiroshi Kasugai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Kasugai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Kasugai more than expected).

Fields of papers citing papers by Hiroshi Kasugai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Kasugai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Kasugai. The network helps show where Hiroshi Kasugai may publish in the future.

Co-authorship network of co-authors of Hiroshi Kasugai

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Kasugai. A scholar is included among the top collaborators of Hiroshi Kasugai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Kasugai. Hiroshi Kasugai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Okusaka, Takuji, Hiroshi Kasugai, Yasukazu Shioyama, et al.. (2009). Transarterial chemotherapy alone versus transarterial chemoembolization for hepatocellular carcinoma: A randomized phase III trial. Journal of Hepatology. 51(6). 1030–1036. 85 indexed citations
3.
Kudo, Masatoshi, Rong Qin Zheng, Soo Ryang Kim, et al.. (2008). Diagnostic Accuracy of Imaging for Liver Cirrhosis Compared to Histologically Proven Liver Cirrhosis. Intervirology. 51(Suppl. 1). 17–26. 122 indexed citations
5.
Ueno, Hideki, Tosiya Sato, Seiichiro Yamamoto, et al.. (2006). Randomized, double‐blind, placebo‐controlled trial of bovine lactoferrin in patients with chronic hepatitis C. Cancer Science. 97(10). 1105–1110. 28 indexed citations
6.
Kudo, Masatoshi, Hobyung Chung, Seiji Haji, et al.. (2004). Validation of A New Prognostic Staging System for Hepatocellular Carcinoma: the Jis Score Compared With the Clip Score. Hepatology. 40(6). 1396–1405. 286 indexed citations
7.
Tatsuta, Masaharu, et al.. (2001). Inhibition byD-limonene of experimental hepatocarcinogenesis in Sprague-Dawley rats does not involve p21ras plasma membrane association. International Journal of Cancer. 93(3). 441–444. 40 indexed citations
8.
Oka, Hiroko, Akiko Saito, Kazuki Ito, et al.. (2001). Multicenter prospective analysis of newly diagnosed hepatocellular carcinoma with respect to the percentage of Lens culinaris agglutinin‐reactive α‐fetoprotein1. Journal of Gastroenterology and Hepatology. 16(12). 1378–1383. 112 indexed citations
9.
Imaoka, Shingi, Yo Sasaki, Hiroshi Nakano, et al.. (1995). The significance of re-hepatectomy for intrahepatic recurrence after hepatectomy for hepatocellular carcinoma.. Kanzo. 36(11). 664–668. 2 indexed citations
10.
Kuroda, C, et al.. (1994). Comparison between conventional and spiral CT in patients with hypervascular hepatocellular carcinoma. European Journal of Radiology. 18(2). 134–136. 21 indexed citations
11.
Hasegawa, Yoshihisa, Tomotaka Sobue, Shingo Ishiguro, et al.. (1994). Analysis of factors affecting uptake of Tc-99m Sn-N-pyridoxyl-5-methyltryptophan by hepatocellular carcinoma. Annals of Nuclear Medicine. 8(2). 139–145. 2 indexed citations
12.
Kasugai, Hiroshi, et al.. (1993). A case of hepatocellular carcinoma with remarkable peliotic change.. Kanzo. 34(9). 747–752.
13.
Kuroda, C, et al.. (1993). MR Features of Various Histological Grades of Small Hepatocellular Carcinoma. Journal of Computer Assisted Tomography. 17(1). 75–79. 20 indexed citations
14.
Tanaka, Sachiko, Tsugio Kitamura, Makoto Fujita, et al.. (1992). Intrahepatic venous and portal venous aneurysms examined by color Doppler flow imaging. Journal of Clinical Ultrasound. 20(2). 89–98. 24 indexed citations
15.
Tsukuma, Hideaki, Tomohiko Hiyama, Akira Oshima, et al.. (1990). A case‐control study of hepatocellular carcinoma in osaka, Japan. International Journal of Cancer. 45(2). 231–236. 60 indexed citations
16.
Hasegawa, Yoshihisa, et al.. (1989). Comparison of Delayed Imaging with Tc-99m PMT and Tc-99m DEIDA for Visualization of Hepatoma. Clinical Nuclear Medicine. 14(7). 526–531. 2 indexed citations
17.
Kasugai, Hiroshi, J Kojima, Masaharu Tatsuta, et al.. (1989). Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intraarterial infusion of a mixture of cisplatin and ethiodized oil. Gastroenterology. 97(4). 965–971. 154 indexed citations
18.
Imaoka, Shingi, Yo Sasaki, Takashi Shibata, et al.. (1989). A pre-operative chemoembolization therapy using lipiodol, cisplatin and gelatin sponge for hepatocellular carcinoma. Cancer Chemotherapy and Pharmacology. 23(S1). S126–S128. 33 indexed citations
19.
Tatsuta, Masaharu, Hisako Yamamura, Hiroyasu Iishi, Hiroshi Kasugai, & Shigeru Okuda. (1986). Value of Serum Alpha-Fetoprotein and Ferritin in the Diagnosis of Hepatocellular Carcinoma. Oncology. 43(5). 306–310. 25 indexed citations
20.
Yamamoto, Reiko, Sanai Noguchi, Masaharu Tatsuta, et al.. (1985). New cell-block method by utilizing egg albumin for fine needle aspiration biopsy.. The Journal of the Japanese Society of Clinical Cytology. 24(2). 150–156. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026